U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2334123341A Randomized Controlled Trial of Hip Dislocation Techniques for Pediatric Patients With Cerebral PalsyNot yet recruitingNo Results AvailableHip Dysplasia|Cerebral PalsyProcedure: Proximal Femoral Resection Arthroplasty|Procedure: Subtrochanteric Valgus Osteotomyhttps://ClinicalTrials.gov/show/NCT02259140
2334223342A Randomised Trial of Dolutegravir (DTG)-Based Antiretroviral Therapy vs. Standard of Care (SOC) in Children With HIV Infection Starting First-line or Switching to Second-line ARTNot yet recruitingNo Results AvailableHIV InfectionDrug: DTGhttps://ClinicalTrials.gov/show/NCT02259127
2334323343A Phase IB Trial With OTX015, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Patients With Selected Advanced Solid TumorsRecruitingNo Results AvailableNUT Midline Carcinoma|Triple Negative Breast Cancer|Non-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation|Castrate-resistant Prostate Cancer (CRPC)|Pancreatic Ductal AdenocarcinomaDrug: OTX015https://ClinicalTrials.gov/show/NCT02259114
2334423344RCT of CBT for Insomnia With PLWHARecruitingNo Results AvailableInsomnia|HIV|AidsBehavioral: CBT-I Treatment Condition|Behavioral: SH Comparison Conditionhttps://ClinicalTrials.gov/show/NCT02259101
2334523345A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese DME PatientsRecruitingNo Results AvailableVision Impairment Due to Diabetic Macular EdemaDrug: ranibizumab|Procedure: laserhttps://ClinicalTrials.gov/show/NCT02259088
2334623346Botox Injection in Treatment of Chronic MigraineRecruitingNo Results AvailableMigraine DisordersDrug: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT02259075
2334723347Listening for Leisure After StrokeRecruitingNo Results AvailableStrokeOther: Music with brief mindfulness intervention|Other: Music listening alone|Other: Audiobook listeninghttps://ClinicalTrials.gov/show/NCT02259062
2334823348The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's DiseaseRecruitingNo Results AvailableBlood PressureDietary Supplement: L-tyrosine|Dietary Supplement: Sugar Pillhttps://ClinicalTrials.gov/show/NCT02259049
2334923349Using Smartphones to Enhance the Treatment of Childhood AnxietyActive, not recruitingNo Results AvailableAnxietyOther: Ecological Momentary Treatment Enhancementhttps://ClinicalTrials.gov/show/NCT02259036
2335023350Discretionary Food Sources and Stress PerceptionActive, not recruitingNo Results AvailableLiquid Beverage Consumption|Solid Dessert ConsumptionOther: Liquid: Sugar sweetened beverage consumption|Other: Solid: Grain based desserts and candy consumptionhttps://ClinicalTrials.gov/show/NCT02259023
2335123351A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Patients With Advanced Solid Tumors or Relapsed/Refractory LymphomaRecruitingNo Results AvailableAdvanced Solid Tumors|Relapsed/Refractory LymphomaDrug: Alisertib|Drug: Itraconazolehttps://ClinicalTrials.gov/show/NCT02259010
2335223352Hepcidin Levels in Sickle Cell Disease (SCD)Enrolling by invitationNo Results AvailableSickle Cell Anemia|Sickle - Beta Thalassemiahttps://ClinicalTrials.gov/show/NCT02258997
2335323353Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP TrialEnrolling by invitationNo Results AvailableSevere Sepsis|Acute Heart FailureDevice: Mespere Venus 1000 Non-Invasive CVP Systemhttps://ClinicalTrials.gov/show/NCT02258984
2335423354Metabolism and Pharmacokinetics of [14C] BEA 2180 BR Administered Orally Compared to [14C] BEA 2180 BR Administered Intravenously in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BEA 2180 BR oral|Drug: BEA 2180 BR infusionhttps://ClinicalTrials.gov/show/NCT02258971
2335523355Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung ResectionCompletedNo Results AvailableVenous Thrombosis|Pulmonary Embolism|Lung Neoplasmshttps://ClinicalTrials.gov/show/NCT02258958
2335623356CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Cross-Sectional StudyActive, not recruitingNo Results AvailableType 1 Diabeteshttps://ClinicalTrials.gov/show/NCT02258945
2335723357CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Longitudinal StudyRecruitingNo Results AvailableType 1 Diabeteshttps://ClinicalTrials.gov/show/NCT02258932
2335823358Decompressive Hemicraniectomy in Intracerebral HemorrhageRecruitingNo Results AvailableCerebral HemorrhageProcedure: Decompressive craniectomy (DC) and best medical treatment|Procedure: Best medical treatmenthttps://ClinicalTrials.gov/show/NCT02258919
2335923359Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial NephrectomyRecruitingNo Results AvailableRenal MassDrug: ulinastatinhttps://ClinicalTrials.gov/show/NCT02258906
2336023360Indoor Air Pollution and Children With Asthma: An Intervention TrialNot yet recruitingNo Results AvailableAsthmaOther: NO2 Scrubber|Other: Nanofilter|Other: Controlhttps://ClinicalTrials.gov/show/NCT02258893
2336123361Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute StrokeWithdrawnNo Results AvailableStrokeDrug: SUN13837https://ClinicalTrials.gov/show/NCT02258880
2336223362Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease UveitisRecruitingNo Results AvailableBehcet's Disease UveitisDrug: Placebo|Drug: Gevokizumabhttps://ClinicalTrials.gov/show/NCT02258867
2336323363An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety DataEnrolling by invitationNo Results AvailableUveitisDrug: Dose 2 gevokizumabhttps://ClinicalTrials.gov/show/NCT02258854
2336423364Effectiveness of an Online Safety Tool for Canadian Women Experiencing Intimate Partner ViolenceRecruitingNo Results AvailableDomestic ViolenceBehavioral: Setting Priorities for Safety|Behavioral: Danger Assessment|Behavioral: Personalized Action Plan|Behavioral: General risk and safety information|Behavioral: Basic Emergency Safety Planhttps://ClinicalTrials.gov/show/NCT02258841
2336523365An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress DisorderCompletedNo Results AvailablePTSDDrug: Memantinehttps://ClinicalTrials.gov/show/NCT02258828
2336623366CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed NeuroblastomaRecruitingNo Results AvailableNeuroblastoma RecurrentDrug: ch14.18/CHOhttps://ClinicalTrials.gov/show/NCT02258815
2336723367Pilot Psychoeducational Intervention Model to Improve Nutritional Status in Low Resource SettingsActive, not recruitingNo Results AvailableChild Malnutrition|Child Overnutrition|Malnutrition in Children|Malnutrition, Child|Nutrition Disorders, Child|MalnutritionBehavioral: Psychoeducational interventionhttps://ClinicalTrials.gov/show/NCT02258802
2336823368Assessment and Training Visio Spatial Neglect in a Virtual Reality EnvironmentCompletedNo Results AvailableHemispatial Neglect|StrokeOther: VR-methodhttps://ClinicalTrials.gov/show/NCT02258789
2336923369The Effect of Pomegranate on Aging and Inflammation of the SkinNot yet recruitingNo Results AvailableSkin Photoaging, Inflammation and Skin Pathogenic BacteriaDietary Supplement: Pomegranate Extract|Dietary Supplement: Pomegranate Juice|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT02258776
2337023370Trial on the Ideal Duration of Oral Antibiotics in Children With PneumoniaRecruitingNo Results AvailablePneumoniaDrug: Amoxicillin-Potassium Clavulanate Combination|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02258763

* Görseller ve İçerik tekif hakkına sahip olabilir